CMPX logo

CMPX
Compass Therapeutics Inc

814
Mkt Cap
$938.26M
Volume
5.06M
52W High
$6.88
52W Low
$1.67
PE Ratio
-11.60
CMPX Fundamentals
Price
$5.03
Prev Close
$5.21
Open
$5.22
50D MA
$5.57
Beta
1.57
Avg. Volume
2.12M
EPS (Annual)
-$0.4216
P/B
4.56
Rev/Employee
$0.00
$647.75
Loading...
Loading...
News
all
press releases
Compass Therapeutics (NASDAQ:CMPX) Stock Price Down 7.6% - Here's What Happened
Compass Therapeutics (NASDAQ:CMPX) Trading Down 7.6% - Here's What Happened...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Investors Buy High Volume of Call Options on Compass Therapeutics (NASDAQ:CMPX)
Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) was the recipient of unusually large options trading on Thursday. Stock traders purchased 20,306 call options on the stock. This represents...
MarketBeat·8d ago
News Placeholder
Compass Therapeutics (NASDAQ:CMPX) Stock Price Up 7.4% - Here's Why
Compass Therapeutics (NASDAQ:CMPX) Trading Up 7.4% - Here's What Happened...
MarketBeat·8d ago
News Placeholder
Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fourteen ratings firms that are covering the company, MarketBeat reports...
MarketBeat·13d ago
News Placeholder
Compass Therapeutics (NASDAQ:CMPX) Trading Down 5.4% - Here's Why
Compass Therapeutics (NASDAQ:CMPX) Stock Price Down 5.4% - Should You Sell...
MarketBeat·14d ago
News Placeholder
Traders Buy High Volume of Compass Therapeutics Call Options (NASDAQ:CMPX)
Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) saw unusually large options trading on Tuesday. Stock traders bought 7,069 call options on the stock. This represents an increase of 411% compared to the average daily volume of 1,383 call options...
MarketBeat·24d ago
News Placeholder
Compass Therapeutics (NASDAQ:CMPX) Receives Buy Rating from Guggenheim
Guggenheim restated a "buy" rating and set a $12.00 price target on shares of Compass Therapeutics in a research note on Tuesday...
MarketBeat·1mo ago
News Placeholder
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Recommendation of "Moderate Buy" by Brokerages
Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the fifteen brokerages that are covering the firm, MarketBeat.com...
MarketBeat·1mo ago
News Placeholder
HC Wainwright Has Positive Estimate for CMPX FY2026 Earnings
Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) - Stock analysts at HC Wainwright lifted their FY2026 earnings estimates for Compass Therapeutics in a report issued on Thursday, March 5th. HC...
MarketBeat·2mo ago
News Placeholder
What is HC Wainwright's Estimate for CMPX Q1 Earnings?
Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Compass Therapeutics in a research report...
MarketBeat·2mo ago
<
1
2
...
>

Latest CMPX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.